Pulse Biosciences (NASDAQ:PLSE) Stock Price Down 8.1%

Pulse Biosciences, Inc. (NASDAQ:PLSE)’s stock price traded down 8.1% during mid-day trading on Tuesday . The company traded as low as $18.83 and last traded at $18.87. 136,419 shares were traded during mid-day trading, a decline of 37% from the average session volume of 214,960 shares. The stock had previously closed at $20.53.

Analyst Upgrades and Downgrades

Separately, StockNews.com raised shares of Pulse Biosciences to a “sell” rating in a report on Tuesday, August 6th.

Pulse Biosciences Stock Performance

The firm has a market capitalization of $1.06 billion, a P/E ratio of -23.79 and a beta of 1.75. The firm’s 50-day moving average is $15.81 and its 200 day moving average is $11.62.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of PLSE. BNP Paribas Financial Markets grew its position in shares of Pulse Biosciences by 63.6% during the 1st quarter. BNP Paribas Financial Markets now owns 7,597 shares of the company’s stock worth $66,000 after purchasing an additional 2,952 shares in the last quarter. Quest Partners LLC bought a new position in Pulse Biosciences in the 2nd quarter valued at approximately $91,000. Price T Rowe Associates Inc. MD bought a new position in Pulse Biosciences in the 1st quarter valued at approximately $88,000. Cetera Advisors LLC bought a new position in Pulse Biosciences in the 1st quarter valued at approximately $109,000. Finally, PNC Financial Services Group Inc. bought a new position in Pulse Biosciences in the 4th quarter valued at approximately $242,000. 76.95% of the stock is currently owned by institutional investors and hedge funds.

Pulse Biosciences Company Profile

Pulse Biosciences, Inc operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology.